Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Clobetasol Propionate Foam, 0.05%
Medication labelWhy this: Advisory · dailymed-prescription
Clobetasol propionate foam, 0.05% is a super-potent topical corticosteroid indicated for short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid- responsive dermatoses of the scalp, and for short-term topical treatment of mild to moderate plaque-type psoriasis on non-scalp regions excluding the face and intertriginous areas. Treatment beyond 2 consecutive weeks is not recommended and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis. In a controlled pharmacokinetic study, some subjects experienced reversible suppression of the adrenals following 14 days of clobetasol propionate foam, 0.05% therapy (See ADVERSE REACTIONS ). Use in children under 12 years of age is not recommended.
- generic_name
- clobetasol propionate
- product_names
- clobetasol propionate
- ndc
- 54868-6291, 66993-888, 54868-6291-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en